LifeTech Scientific Corp
HKEX:1302
Net Margin
LifeTech Scientific Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
LifeTech Scientific Corp
HKEX:1302
|
7.3B HKD |
17%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
227.4B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
192.2B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.6B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143.9B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.4B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.1B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.1B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.5B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
281.2B CNY |
31%
|
LifeTech Scientific Corp
Glance View
LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on LifeTech Scientific Corp's most recent financial statements, the company has Net Margin of 17.1%.
You don't have any saved screeners yet